Statins and bone health: a mini review

Main Article Content

Leslie R. Morse
Jennifer Coker
Ricardo A. Battaglino

Abstract

Statins are a widely prescribed class of medications that inhibit similar pathways as the anti-resorptive bisphosphonate drugs.
Statins target the mevalonate pathway by blocking HMG-CoA reductase. Several recent meta-analyses concluded statins are osteoprotective in the general population. Here we present current literature exploring the mechanisms underlying the putative osteoprotective effects of statins. We also review recent clinical studies, ranging from observational cohort studies to randomized clinical trials, testing the effect of statins on bone health in various populations.

Article Details

How to Cite
1.
Morse LR, Coker J, Battaglino RA. Statins and bone health: a mini review. Actual. Osteol. [Internet]. 2024 Jun. 29 [cited 2024 Nov. 22];14(1):31-5. Available from: https://ojs.osteologia.org.ar/ojs33010/index.php/osteologia/article/view/185
Section
Reviews